Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amedisys, Inc. stock logo
AMED
Amedisys
$97.92
-0.1%
$95.28
$82.15
$98.95
$3.21B0.94420,148 shs397,167 shs
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$103.36
+0.8%
$106.65
$72.21
$139.13
$5.09B0.47671,645 shs1.18 million shs
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$15.27
+1.7%
$15.39
$14.03
$40.98
$1.96B1.34980,140 shs3.25 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$8.43
+4.7%
$7.19
$6.35
$15.21
$1.48B1.786.34 million shs18.17 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amedisys, Inc. stock logo
AMED
Amedisys
-0.11%+0.47%+4.60%+5.63%+6.43%
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
+0.77%+2.65%+0.36%-12.80%+34.02%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
+1.68%+2.97%+3.99%-9.20%-54.92%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
+5.10%+22.04%+20.73%+3.84%-16.98%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amedisys, Inc. stock logo
AMED
Amedisys
2.6487 of 5 stars
1.11.00.05.02.01.71.3
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
4.6217 of 5 stars
4.51.00.04.51.34.20.6
Select Medical Holdings Corporation stock logo
SEM
Select Medical
5 of 5 stars
3.45.02.54.82.14.25.0
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
3.3385 of 5 stars
3.24.00.00.02.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amedisys, Inc. stock logo
AMED
Amedisys
2.20
Hold$100.752.89% Upside
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3.06
Buy$172.3366.73% Upside
Select Medical Holdings Corporation stock logo
SEM
Select Medical
2.80
Moderate Buy$26.0070.32% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.37
Hold$9.6013.89% Upside

Current Analyst Ratings Breakdown

Latest TDOC, SEM, AXSM, and AMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/12/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$193.00 ➝ $186.00
6/10/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$180.00
6/9/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$153.00 ➝ $150.00
6/3/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$185.00
5/28/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$8.00 ➝ $7.00
5/27/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$10.00 ➝ $9.00
5/22/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$180.00 ➝ $180.00
5/14/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/8/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.00
5/7/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$200.00 ➝ $180.00
5/7/2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$23.00 ➝ $19.00
(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amedisys, Inc. stock logo
AMED
Amedisys
$2.35B1.37$6.23 per share15.71$36.03 per share2.72
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$385.69M13.20N/AN/A$1.18 per share87.59
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$5.19B0.38$2.50 per share6.10$15.35 per share0.99
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.57B0.58$5.58 per share1.51$8.66 per share0.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amedisys, Inc. stock logo
AMED
Amedisys
$43.23M$2.7136.1320.231.333.79%12.52%7.01%7/23/2025 (Estimated)
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
-$287.22M-$5.77N/A36.65N/A-64.39%-272.80%-36.69%8/4/2025 (Estimated)
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$214.04M$1.3411.3910.830.812.81%11.04%3.25%7/30/2025 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$1.00B-$5.92N/AN/AN/A-39.66%-11.01%-4.66%7/30/2025 (Estimated)

Latest TDOC, SEM, AXSM, and AMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Amedisys, Inc. stock logo
AMED
Amedisys
$1.39N/AN/AN/A$614.61 millionN/A
5/1/2025Q1 2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$0.45$0.44-$0.01$0.44$1.40 billion$1.35 billion
4/23/2025Q1 2025
Amedisys, Inc. stock logo
AMED
Amedisys
$1.13$1.25+$0.12$1.84$597.43 million$594.78 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amedisys, Inc. stock logo
AMED
Amedisys
N/AN/AN/AN/AN/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
N/AN/AN/AN/AN/A
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$0.251.64%N/A18.66%N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A

Latest TDOC, SEM, AXSM, and AMED Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
quarterly$0.06251.37%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amedisys, Inc. stock logo
AMED
Amedisys
0.27
1.29
1.29
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3.48
2.03
1.96
Select Medical Holdings Corporation stock logo
SEM
Select Medical
0.87
1.16
1.16
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.70
1.68
1.64

Institutional Ownership

CompanyInstitutional Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
94.36%
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
81.49%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
89.48%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%

Insider Ownership

CompanyInsider Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
2.10%
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
22.30%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
11.60%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.58%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amedisys, Inc. stock logo
AMED
Amedisys
19,00032.82 million32.13 millionOptionable
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
38049.24 million38.26 millionOptionable
Select Medical Holdings Corporation stock logo
SEM
Select Medical
44,100128.54 million113.63 millionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,500175.43 million174.42 millionOptionable

Recent News About These Companies

Zacks Research Cuts Earnings Estimates for Teladoc Health
Teladoc Health to Face Bulk of Pixel Tracking, Data Sharing Suit
Divita lays out Teladoc's M&A strategy in CEO's 2nd year
Omada Health: Helping Patients, Investors As Well?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amedisys stock logo

Amedisys NASDAQ:AMED

$97.92 -0.11 (-0.11%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$97.94 +0.02 (+0.02%)
As of 06/27/2025 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Axsome Therapeutics stock logo

Axsome Therapeutics NASDAQ:AXSM

$103.36 +0.79 (+0.77%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$103.42 +0.06 (+0.05%)
As of 06/27/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Select Medical stock logo

Select Medical NYSE:SEM

$15.26 +0.26 (+1.70%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$15.26 0.00 (0.00%)
As of 06/27/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

Teladoc Health stock logo

Teladoc Health NYSE:TDOC

$8.43 +0.38 (+4.68%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$8.52 +0.09 (+1.04%)
As of 06/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.